History of prostate cancer in relatives may increase risk of breast cancer
the ONA take:
A recent study explored the impact of having a family history of cancer on a person’s risk of developing cancer, with a new twist.
Women with a family history of prostate cancer in first-degree relatives (fathers, brothers, sons) may have a higher risk of developing breast cancer.
Evidence indicates that having a family history of breast or prostate cancer increases a person’s risk of developing the same disease; however, the relationship between breast and prostate cancer within families is not well known.
Researchers at the Barbara Ann Karmanos Cancer Institute reviewed the cases from 78,171 women who enrolled in the Women’s Health Initiative Observational Study between 1993 and 1998 and did not have breast cancer at the start of the study.
At the end of the study, a total of 3,506 cases of breast cancer were diagnosed. Study results linked a family history of prostate cancer in first-degree relatives with a 14% increase in risk of developing breast cancer.
The researchers noted that patients and clinicians may not consider cancers in family members of the opposite sex.
However, these results suggest that clinicians should take a complete family history of all cancers, particularly among first-degree relatives, to assess a patient’s risk for developing cancer.
Women with a family history of prostate cancer in first-degree relatives may have a higher risk of developing breast cancer.
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Immune Thrombocytopenia (Fact Sheet)
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|